Press Releases

Innovative technology to enhance level of patient care, improve office efficiencies

- Highest recognition for a commitment to the renewal of US-European relations -

ImmYounity(SM) campaign unveiled as new resource for health-care professionals and consumers

Local Demonstration Program to Implement Community-Based Diabetes Management Announced

Sanofi Collaborates with Leading Health Organizations to Help Men Take More Proactive Stance in Managing Their Disease

- Performance driven by growth platforms, Genzyme acquisition and cost savings -

Elderly patients receiving the high-dose flu vaccine had a more robust immune response to vaccination with antibody levels similar to those typical in younger adults

Addition of fourth strain to influenza vaccine intended to address potential for a mismatch between strains selected for vaccine and circulating influenza viruses

- Findings from Two-Year Pivotal Phase III TEMSO Trial Published today in The New England Journal of Medicine -

Nationwide Recipe Contest Elevates Awareness for Proper Diabetes Management

New online community for managed care leaders

AFib Educator 2.0" Includes New Animations, Resources to Improve Patient-Physician Dialogue

Sanofi demonstrates commitment to wellness and prevention starts with its own employees

U.S. Senator Robert P. Casey, Jr. and Msgr. Joseph G. Quinn Co-Chair Record Breaking Event

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season

Fluzone® Intradermal (Influenza Virus Vaccine) offers adults new immunization option for 2011-2012 influenza season

-- Focused effort to reach mothers, the family's "chief medical officer"

National AFib Education Campaign Launches to Help Improve the Care of People with This Serious and Increasingly Prevalent(1) Form of Irregular Heartbeat

- Weight gain was lowest in patients with baseline A1C below 8 percent and in patients 65 years and older -

- New phase III data from GetGoal-F1 study of once-daily lixisenatide support simplified treatment initiation -

Four local non-profits receive donations totaling more than $180,000

Positive impact from Genzyme on business EPS(1)

Greg Irace, Senior Vice President, Global Services

Early shipments of Fluzone and Fluzone High-Dose vaccines support health-care providers in immunization planning and provide additional opportunities to increase immunization rates

- Strategic Divestiture to focus on Growth Platforms in the United States and Canada -

Company has sponsored high school biotechnology competition for almost 20 years

- Data Presented at American Diabetes Association's 71st Annual Scientific Sessions -

- Once-Daily Lyxumia® Demonstrates Non-Inferior Reduction of Blood Glucose and Less Hypoglycemia versus Exenatide Twice Daily in Type 2 Diabetes Patients -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

- Over 500 Million Patients Suffer from Hearing Loss Worldwide with No Currently Available Disease-Modifying Treatments -

Diabetes Co-Stars: Cook-Off Invites People to Share Diabetes-Friendly Recipes

Donation Helps Four-time NASCAR Cup Series Champion Jeff Gordon Shift Relief Efforts into High Gear

- Results of Phase III SAVE-ONCO study selected for "Best of ASCO 2011" -

U.S. locations launch a “Walking Club” and promote a myriad of programs offered to employees to improve overall health and wellness

Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle

- Indication Provides New Option to Help Protect Earlier Against Meningococcal Disease -

"AFib in America: State Impact Reports" Illustrate the Disconnect Between AFib's Impact and the Public Health Resources Available

The Coalition to Prevent DVT Promotes Education to Fill the Gap between DVT Risk and Co-Morbid Patients

Sanofi Pasteur stands shoulder to shoulder with Rotary International during NYSE and EURONEXT bell-ringing ceremonies

- WNBA, NBA Development League and NBA All-Star Dwight Howard, WNBA All-Star Alana Beard and NBA Legends Walt Frazier and Chris Dudley will also Raise Awareness about Diabetes -

Combination will enhance sanofi-aventis' sustainable growth strategy by expanding its footprint in biotechnology

- First industry partner for UCSF's Program for Breakthrough Biomedical Research (PBBR) -

- Collaboration promotes clinical and translational research to address unmet needs of cancer patients in India -

Final 10-year combination chemotherapy adjuvant survival data, studies of investigational agent iniparib to be featured at breast cancer symposium

Vaccine against one of the most common causes of hospital-acquired infection in North America & Europe tested in the U.S.

Investigational Intradermal Influenza Vaccine Induced Comparable Immune Responses to Licensed Fluzone Vaccine with Less Antigen, Smaller Injection Volume

- Focused on translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation -

World’s Largest Influenza Vaccine Producer Awarded $57 Million To Maintain Year-Round Egg Supply for Influenza Pandemic Planning

- Results of the Phase III TROPIC global study published -

Technology of in-vitro Models of the Human Immune System to Provide Competitive Advantage in Vaccine Development

Repeated Doctors Visits, ER Trips, and Admissions to Inpatient/Outpatient Facilities Create High Costs for Managing Patients with a Common, Complex Cardiovascular Disease

-'Diabetes Co-Stars' Offers Information and Support to People Living with Diabetes, Family and Friends -

- Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting -

- Phase III Study Results also demonstrated the therapy had acceptable safety profile -

Hundreds of thousands of doses of vaccine and medical supplies also provided

- Funding supports programs to advance personalized medicine -

- 1-vial Taxotere offers simplified preparation -

Early shipments support national goal to increase immunization rates

- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -

- Study Results Presented at American Diabetes Association's 70th Annual Scientific Sessions -

- First and only therapy to provide significant survival benefit in second-line metastatic hormone-refractory prostate cancer -

- Alliance formed to advance cutting-edge research and foster collaboration between academia and industry -

- Sanofi-aventis Supports Consortium's Activities to Fund Promising Early-Stage Life Sciences Companies -

The licensed technology was developed by the NMRC with the help of the University of Colorado

Interactive Exhibit Unveiled at New Jersey's Liberty Science Center as it Embarks on Three-Year, 12-City Tour

Chattem Becomes the U.S. Consumer Healthcare Platform for sanofi-aventis

- Results observed in patients treated with cabazitaxel plus prednisone whose disease progressed despite prior docetaxel-based chemotherapy -

The Coalition to Prevent DVT Sends Awareness into Motion with an Educational Program Focusing on Preventative Care Through Movement

New Data Published by Journal of American Academy of Dermatology Demonstrated Sustained Efficacy Up to 25 Months

"AFib Support Team" Offers Insights on Comprehensive Approach to Management of Serious Heart Condition